1. Nowicki R, Trzeciak M, Wilkowska A, Wojdylo MS, Umer HL, Rybak WB. Atopic dermatitis: current treatment guidelines. Statement of the experts of the dermatological section, polilsh society of allergology, and the allergology section. Postep derm Alergol. 2015;32(4):239-249.
2. Zuuren EJV, Apfelbachr SJ, Fedorowicz Z, Jupiter A, Matterne U. No high level evidence to support the use of oral H1 antihistamines as monotherapy for eczema: a summary of a Cochrane systemic review. 2014;25(3):1-5.
3. Yarbrough KB, Neuhaus KJ, Simpson EL. The effects of treatment on itch in atopic dermatitis. Dermatol Ther. 2013;26(2):110-119.
4. Stander S, Luger TA, Itch in atopic dermatitis – pathophysiology and treatment. Acta Dermatovenerol Croat. 2010;18(4):289-296.
5. Yosipovitch G, Papoiu ADP. What causes itch in atopic dermatitis. Current Allergy and Asthma Reports. 2008;8:306-311.
6. Kim EJ, Kim HJ, Lew BL, Lee KH, Hong SP, Jang YH, et al. consensus guidelines for the treatment of atopic dermatitis in korea (part II): systemic treatment. Ann Dermatol. 2015;27(5):. 578-93.
7. Matterne W, Bohmer MM, Weisshar E, Jupiter A, CarterB. Oral h1 antihistamines as ‘add-on’ therapy to topical treatment for eczema. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD012167.pub2
8. Munasir Z, Esmeralda ND, Rundjan L, Safri M, Putra AR. Clinical effectiveness of 6 months cetirizine administration to prevent atopic dermatitis recurrence in children: a randomized trial. HVM International Journal of the Bioflux Society. 2017;9(2):53-57.
9. Yamanaka K, Motomura E, Noro Y, Umeda K, Morikawa T, Togami KU, et al. olopatadine, a non-sedating H1 antihistamine, decreases the nocturnal scratching without affecting sleep quality in atopic dermatitis. Experimental dermatology. 2015;24(3). https://doi.org/10.1111/exd.12630
10. Tay CJ, et al. Effectiveness of antihistamines for itch and sleep disturbance in atopic dermatitis: a retrospective cohort study. Itch, 2021. 6(2):p e47. DOI: 10.1097/itx.0000000000000047